Page last updated: 2024-12-05

mesitylene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

mesitylene: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

1,3,5-trimethylbenzene : A trimethylbenzene carrying methyl substituents at positions 1, 3 and 5. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID7947
CHEMBL ID1797281
CHEBI ID34833
MeSH IDM0055564

Synonyms (68)

Synonym
BIDD:ER0286
s-trimethylbenzene
1,3,5-trimethylbenzene
3,5-dimethyltoluene
CHEBI:34833 ,
hsdb 92
einecs 203-604-4
nsc 9273
trimethylbenzene, 1,3,5-
ai3-23973
un2325
wln: 1r c1 e1
mesitylene
fleet-x
trimethylbenzol
nsc9273
nsc-9273
108-67-8
sym-trimethylbenzene
benzene, 1,3,5-trimethyl-
benzene,1,3,5-trimethyl
inchi=1/c9h12/c1-7-4-8(2)6-9(3)5-7/h4-6h,1-3h
mesitylene, 98%
S0658
T0470
AKOS000120144
A801911
NCGC00247999-02
NCGC00247999-01
CHEMBL1797281
dtxsid6026797 ,
NCGC00259003-01
tox21_300341
NCGC00254430-01
dtxcid506797
cas-108-67-8
tox21_201452
1,3,5-trimethyl-benzene
unii-887l18kq6x
1,3,5-trimethylbenzene [un2325] [flammable liquid]
ec 203-604-4
887l18kq6x ,
ccris 8147
FT-0606520
STL268905
mesitylene [mi]
2,4,6-trimethylbenzene
mesitylene [hsdb]
mesitylene [inci]
38574-14-0
un 2325
STR03436
J-002179
J-521685
F0001-0175
symmetrical trimethylbenzene
mfcd00008538
mesitylene, analytical standard
mesitylene, certified reference material, tracecert(r)
mesitylene, purum, >=98.0% (gc)
mesitylene, reagent grade, 97%
1,3,5-trimethylbenzene (mesitylene)
mesitylene (acd/name 4.0)
1,3, 5-trimethylbenzene
Q425161
EN300-19371
Z104473654
mesitelene

Research Excerpts

Actions

ExcerptReferenceRelevance
"Mesitylene promotes the formation of capsule-like superstructures, whereas toluene results in the formation of helices as intermediates during the course of crystallization."( From Capsule to Helix: Guest-Induced Superstructures of Chiral Macrocycle Crystals.
Alimi, LO; Cavallo, L; Chand, S; Dey, A; Ghosh, M; Khashab, NM, 2020
)
1.28

Dosage Studied

ExcerptRelevanceReference
" after dosage show that this substance does not accumulate in the body."( THE FATE OF 2,4,6-TRI-(3',5'-DI-TERT.-BUTYL-4'-HYDROXYBENZYL)MESITYLENE (IONOX 330) IN THE DOG AND RAT.
CROWNE, RS; HATHWAY, DE; WRIGHT, AS, 1965
)
0.48
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
trimethylbenzene
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency30.43380.003041.611522,387.1992AID1159552; AID1159555
estrogen nuclear receptor alphaHomo sapiens (human)Potency22.90620.000229.305416,493.5996AID743069; AID743075
activating transcription factor 6Homo sapiens (human)Potency2.15890.143427.612159.8106AID1159516
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID603957Octanol-water partition coefficient, log P of the compound2008European journal of medicinal chemistry, Apr, Volume: 43, Issue:4
QSPR modeling of octanol/water partition coefficient for vitamins by optimal descriptors calculated with SMILES.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (64)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (14.06)18.7374
1990's9 (14.06)18.2507
2000's21 (32.81)29.6817
2010's21 (32.81)24.3611
2020's4 (6.25)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 66.43

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index66.43 (24.57)
Research Supply Index4.22 (2.92)
Research Growth Index4.74 (4.65)
Search Engine Demand Index110.19 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (66.43)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (3.08%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other63 (96.92%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]